HR 6994 United States House · 119th Congress

Mental Health TALK SAFE Act of 2026

The Mental Health TALK SAFE Act of 2026 amends the Controlled Substances Act to allow telehealth prescribing of certain controlled substances for mental health treatment. It establishes requirements for telehealth entities that prescribe these substances, including minimum staffing standards (like employing at least 250 psychiatrists working 30+ hours weekly), mandatory compliance officers, and restrictions on practitioner compensation structures. The bill prohibits pharmacists from refusing to fill prescriptions issued via telehealth based solely on the method of evaluation, requiring them to attempt validation through communication with the patient or prescriber first. It affects telehealth entities, psychiatrists, and psychiatric-mental health advanced practice nurses providing remote mental health care services. The legislation preempts state laws that would restrict these telehealth prescribing practices for mental health conditions.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
President
Introduced Jan 9, 2026 Last action Jan 9, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Jan 9, 2026
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Jan 9, 2026
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor

Sponsors